外渗
氯硝柳胺
静脉注射
癌症研究
细胞
细胞生物学
化学
转移
内皮干细胞
血管通透性
医学
生物
免疫学
病理
癌症
体外
内科学
生物化学
生态学
作者
Georg Hilfenhaus,Ana Mompeón,Jonathan Freshman,Divya P. Prajapati,Gloria E. Hernandez,Vanessa M. Freitas,Feiyang Ma,Adam D. Langenbacher,Snezana Mirkov,Dana Song,Byoung-Kyu Cho,Young Ah Goo,Matteo Pellegrini,Jau‐Nian Chen,Robert Damoiseaux,M. Luisa Iruela‐Arispe
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2020-11-20
卷期号:81 (3): 619-633
被引量:11
标识
DOI:10.1158/0008-5472.can-19-3911
摘要
Abstract Metastases largely rely on hematogenous dissemination of tumor cells via the vascular system and significantly limit prognosis of patients with solid tumors. To colonize distant sites, circulating tumor cells must destabilize the endothelial barrier and transmigrate across the vessel wall. Here we performed a high-content screen to identify drugs that block tumor cell extravasation by testing 3,520 compounds on a transendothelial invasion coculture assay. Hits were further characterized and validated using a series of in vitro assays, a zebrafish model enabling three-dimensional (3D) visualization of tumor cell extravasation, and mouse models of lung metastasis. The initial screen advanced 38 compounds as potential hits, of which, four compounds enhanced endothelial barrier stability while concurrently suppressing tumor cell motility. Two compounds niclosamide and forskolin significantly reduced tumor cell extravasation in zebrafish, and niclosamide drastically impaired metastasis in mice. Because niclosamide had not previously been linked with effects on barrier function, single-cell RNA sequencing uncovered mechanistic effects of the drug on both tumor and endothelial cells. Importantly, niclosamide affected homotypic and heterotypic signaling critical to intercellular junctions, cell–matrix interactions, and cytoskeletal regulation. Proteomic analysis indicated that niclosamide-treated mice also showed reduced levels of kininogen, the precursor to the permeability mediator bradykinin. Our findings designate niclosamide as an effective drug that restricts tumor cell extravasation through modulation of signaling pathways, chemokines, and tumor–endothelial cell interactions. Significance: A high-content screen identified niclosamide as an effective drug that restricts tumor cell extravasation by enhancing endothelial barrier stability through modulation of molecular signaling, chemokines, and tumor–endothelial cell interactions.
科研通智能强力驱动
Strongly Powered by AbleSci AI